In this study, we sought to combine three tumor markers, CK20, EpCAM, and Pan-CK, through triple-parameter FCM (tFCM), with the aim of evaluating whether tFCM could enhance the precision and efficiency of LN metastasis detection in CRC patients. The gene discussed is KRT20; the disease is colorectal carcinoma.